eight patients with lichen sclerosus and 8 patients with localized scleroderma were treated with etretinate ( tigason ) at doses of 0.5 mg/kg body weight for between 3 and 12 months : 2 of 3 patients with juvenile type lichen sclerosus cleared , whereas the lesions of 5 patients with balanitis xerotica obliterans , kraurosis vulvae and extragenital lichen sclerosus were unchanged or even progredient .
C0015137
etretinate
C0729231
tigason